p jnk (Affinity Biosciences)
Structured Review
P Jnk, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+jnk/anti+jnk/pmc12914111-39-61-70
Average 86 stars, based on 1 article reviews
Images
Related Articles
Pyrolysis Gas Chromatography:Article Title: Network pharmacology reveals that Yanghe Decoction inhibits osteosarcoma progression via ROS-induced mitochondrial dysfunction and enhances cisplatin sensitivity Article Snippet: Cyclin B (#4138), Vimentin (#5741), N-cadherin (#13116), p38 (#9212), and p-p38 (#4511S) antibodies were purchased from Cell Signaling Technology (USA). .. Cytochrome c (CYT-C) (#AF0146), cleaved-PARP (#AF7023), Bcl-2 (#AF6139), cleaved-caspase 9 (#AF5240), cleaved-caspase 3 (#AF7022), matrix metalloproteinase 2 (MMP2) (#AF5330), MMP7 (#AF0218), peroxisome proliferator-activated receptor-γ-coactivator 1α (PGC-1α) (#AF5395), nuclear respiratory factor 1 (NRF1) (#AF5298), NRF2 (#AF0639), mitochondrial transcription factor A (TFAM) (#AF0531), PI3K (#AF6241), p-PI3K (#AF3242), AKT (#AF6261), p-AKT (#AF0016), extracellular signal-related kinase (ERK) (#AF0155), Jun N-terminal kinase (JNK) (#AF6318), p-ERK (#AF1015), other:Article Title: Xiaoyao San against depression via glia-mediated neuroinflammation using network pharmacology and experimental validation Article Snippet: Article Title: Integrating network pharmacology and experimental validation strategies to investigate the mechanisms and key flavonoids in medicinal and edible citrus plants against Alzheimer’s disease Article Snippet: Incubation:Article Title: Targeting TNFAIP2 with NIR-II CRISPR-Cas9 nanosystem to overcome cisplatin resistance in laryngeal cancer Article Snippet: Equal amounts of protein were separated by SDS-PAGE and transferred to polyvinylidene fluoride (PVDF) membranes (FFP19, Beyotime, China). .. Membranes were blocked with 5% BSA (ST025-5g, Beyotime, China) for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies (dilution 1:1000 unless otherwise noted): anti-ABCG2 (rabbit, AF5177, Affbiotech, China), MDR1 (rabbit, AF5185, Affbiotech, China), CD44 (rabbit, DF6392, Affbiotech, China), CD133 (rabbit, AF5120, Affbiotech, China), Snail (rabbit, AF6032, Affbiotech, China), Slug (rabbit, AF4002, Affbiotech, China), Twist1 (rabbit, AF4009, Affbiotech, China), Vimentin (rabbit, AF7013, Affbiotech, China), E-cadherin (rabbit, AF0131, Affbiotech, China), ZO-1 (rabbit, AF5145, Affbiotech, China), JNK (rabbit, AF6318, Affbiotech, China), |

